undamentalytics Newsletter

Murphy John Raymond: insider trades

Director at 2 companies we cover. 6 open-market purchases and 29 sales not made under a pre-set plan, reported from May 21, 2010 to May 20, 2026.

Would copying Murphy John Raymond’s purchases have beaten the S&P 500?

Too few purchases to judge. Only 3 purchases have 12 months of prices after the report; we judge insiders once they have 20. The figures below can swing a long way on a handful of trades. Buying each purchase the day after it was reported, an equal amount each, and holding it 12 months or until they reported a sale would have turned $10,000 on February 22, 2012 into $16,044 by November 2, 2026, +3.3% a year. The copy held shares only 12% of the time, so the fair comparison is the S&P 500 on those same days with Treasury bills otherwise: $16,615, +3.5% a year (the S&P 500 held throughout made $71,758, +14.4% a year). Beta against the index was 0.04. Twelve months after each report, the average purchase was −1.4% against the S&P 500 (median +7.6%), and 67% beat it. Measured from the trade date, the insider’s own timing, the average was −2.3%. After their sales, the shares moved +9.5% against the index over 12 months on average (a negative figure means selling was the right call); 37% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

$0$20.0k$40.0k$60.0k 20122014201620182020202220242026 $71.8k$16.6k$16.0k
Copying Murphy John RaymondS&P 500, same days investedS&P 500, held throughout $10,000 copying Murphy John Raymond’s open-market purchases from February 22, 2012, before costs and taxes, marked weekly. Each purchase gets the same starting stake, bought at the close of the first trading day after the report and sold 12 months later or the day after a reported sale of that stock; uninvested money earns the Treasury bill rate. “Same days invested” holds the S&P 500 only on the days the copy held shares, Treasury bills otherwise.
Return a year, copying
+3.3%
S&P 500, same days invested
+3.5% (held throughout +14.4%)
Time in shares
12%
Sharpe ratio (S&P 500)
0.22 (0.79)
Biggest drop (S&P 500)
−25% (−34%)
Market sensitivity (beta)
0.04
Purchases copied
3

Trade by trade

Murphy John Raymond: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 3 +0.9% −2.1% 33% 3 — — Not enough years
Purchases, 6 months after the report 3 −3.9% −4.0% 33% 3 — — Not enough years
Purchases, 12 months after the report 3 −1.4% +7.6% 67% 3 — — Not enough years
Purchases, 12 months after the trade 3 −2.3% +5.6% 67% 3 — — Not enough years
Sales, 3 months after the report 29 +1.4% +0.9% 48% 16 0.02 0.98 No reliable evidence
Sales, 12 months after the report 27 +9.5% +3.9% 37% 15 1.27 0.22 No reliable evidence
Sales, 12 months after the trade 27 +9.4% +6.5% 37% 15 1.30 0.21 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
O'Reilly Automotive ORLY —329May 21, 2010May 20, 2026
Cadrenal Therapeutics, Inc. CVKD —30March 16, 2023October 6, 2023

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
May 20, 2026May 18, 2026 ORLY Sale $230,099 −6.9%not yetnot yet
November 6, 2025November 4, 2025 ORLY Sale $289,375 −7.2%not yetnot yet
May 20, 2025May 19, 2025 ORLY Sale $275,800 +3.2%−29.0%−26.8%
February 15, 2024February 13, 2024 ORLY Sale $279,566 −10.0%+1.1%+1.9%
November 2, 2023October 31, 2023 ORLY Sale $232,418 −3.7%−12.5%−13.9%
October 6, 2023October 4, 2023 CVKD Purchase $13,973 not yetnot yetnot yet
May 4, 2023May 2, 2023 ORLY Sale $277,368 −10.6%−18.6%−17.3%
March 22, 2023March 21, 2023 CVKD Purchase $13,900 not yetnot yetnot yet
March 16, 2023March 16, 2023 CVKD Purchase $33,400 not yetnot yetnot yet
February 22, 2023February 14, 2023 ORLY Sale $255,018 +7.4%−1.9%−1.8%
August 4, 2022August 2, 2022 ORLY Sale $211,647 +25.5%+20.8%+19.6%
May 12, 2021May 11, 2021 ORLY Sale $265,188 −1.2%+15.4%+11.7%
November 13, 2020November 12, 2020 ORLY Sale $90,468 −8.8%+10.1%+7.9%
August 6, 2020August 4, 2020 ORLY Sale $117,618 −8.3%−5.4%−6.9%
October 31, 2019October 29, 2019 ORLY Sale $109,665 −14.7%−8.9%−8.0%
August 1, 2019July 30, 2019 ORLY Sale $47,082 +13.6%+13.5%+8.6%
May 23, 2019May 21, 2019 ORLY Sale $190,634 +1.6%+0.9%+6.5%
August 23, 2018August 23, 2018 ORLY Sale $132,512 +14.1%+12.2%+11.4%
May 3, 2018May 1, 2018 ORLY Sale $153,462 +13.1%+31.8%+35.2%
February 15, 2018February 13, 2018 ORLY Sale $98,068 +8.6%+48.9%+51.0%
May 5, 2017May 3, 2017 ORLY Sale $148,062 −23.1%−8.8%−7.4%
November 3, 2016November 1, 2016 ORLY Purchase $131,980 −10.0%−46.7%−45.9%
February 19, 2016February 16, 2016 ORLY Sale $128,095 −7.1%−20.5%−20.4%
November 4, 2015November 3, 2015 ORLY Sale $152,674 −3.4%−5.9%−4.8%
May 12, 2015May 11, 2015 ORLY Sale $139,501 +12.6%+20.3%+20.8%
February 12, 2015February 10, 2015 ORLY Sale $66,683 +6.8%+32.1%+23.5%
November 5, 2014November 3, 2014 ORLY Sale $196,377 +12.9%+46.7%+47.7%
May 1, 2014April 30, 2014 ORLY Purchase $148,490 −2.1%+35.0%+33.5%
April 30, 2014April 29, 2014 ORLY Sale $145,450 −1.6%+36.0%+33.0%
November 15, 2012November 13, 2012 ORLY Sale $179,100 +0.9%+3.9%+7.4%
February 21, 2012February 14, 2012 ORLY Purchase $83,240 +14.8%+7.6%+5.6%
February 16, 2012February 14, 2012 ORLY Sale $207,800 +14.8%+6.5%+5.6%
November 3, 2011November 1, 2011 ORLY Sale $561,800 +0.9%+1.2%−3.0%
May 6, 2011May 6, 2011 ORLY Sale $300,000 +12.7%+68.0%+70.1%
May 21, 2010May 19, 2010 ORLY Sale $243,200 −1.0%−1.0%+0.8%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Murphy John Raymond traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.